Evaluation of Iron(iii)-N(amine)2N(py)2 complexes as potential bioreductively activated carriers for naphthoquinone-based drugs

Carregando...
Imagem de Miniatura

Data

Título da Revista

ISSN da Revista

Título de Volume

Editor

Universidade Federal de Minas Gerais

Descrição

Tipo

Artigo de periódico

Título alternativo

Primeiro orientador

Membros da banca

Resumo

Two new iron(III) complexes, [Fe(bhnq)(L1)]NO3·CH3OH·2H2O (1) and [Fe(bhnq)(L2)]ClO4·CH3OH (2) (L1 = N,N′-bis(pyridin-2-ylmethyl)ethylenediamine and L2 = N,N′-dimethyl-N,N′-bis(pyridin-2-ylmethyl)ethylenediamine), were investigated as potential candidates for bioreductively activated prodrugs. These complexes present a distorted octahedral structure with 2,2′-bis(3-hydroxy-1,4-naphthoquinone), (bhnq)2−, coordinated in a bidentate fashion to the iron(III) ion. A reversible wave associated with the Fe3+/Fe2+couple was observed in MeCN for 1 and 2 respectively at −0.05 V and 0.01 V versus SHE. Unlike previously studied cobalt(III)-based analogs and one iron(III) platform that showed efficient bioreductive activation, complexes 1 and 2 undergo fast dissociation in aqueous buffered solutions with immediate release of the bhnq2− ligand. Therefore, we conclude that the labile 3d5 iron(III) ion is a limited bioreducible carrier for naphthoquinone-based prodrugs when coordinated to this [N2NPy2] platform. Considerable modification of the current ligands or the meticulous selection of other alternative ligand platforms may be necessary to attain this goal.

Abstract

Assunto

Ferro, Anoxemia

Palavras-chave

Bioreductively activated prodrugs, Prodrugs activated by hypoxia, Bioreducible carrier, Iron

Citação

Curso

Endereço externo

https://www.sciencedirect.com/science/article/pii/S0277538716305393

Avaliação

Revisão

Suplementado Por

Referenciado Por